LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | AZD 5438 | 1.11 | uM | LJP6 | 2 | J03 | 72 | hr | 513 | 537 | 10386 | 0.0517 | 0.0104 |
MCF 10A | AZD 5438 | 1.11 | uM | LJP6 | 3 | J03 | 72 | hr | 513 | 593 | 10494 | 0.0565 | 0.0337 |
MCF 10A | AZD 5438 | 3.33 | uM | LJP6 | 1 | J02 | 72 | hr | 513 | 728 | 10537 | 0.0691 | 0.0834 |
MCF 10A | AZD 5438 | 3.33 | uM | LJP6 | 2 | J02 | 72 | hr | 513 | 653 | 10386 | 0.0629 | 0.0570 |
MCF 10A | AZD 5438 | 3.33 | uM | LJP6 | 3 | J02 | 72 | hr | 513 | 731 | 10494 | 0.0697 | 0.0846 |
MCF 10A | AZD 5438 | 10 | uM | LJP6 | 1 | J01 | 72 | hr | 513 | 593 | 10537 | 0.0563 | 0.0336 |
MCF 10A | AZD 5438 | 10 | uM | LJP6 | 2 | J01 | 72 | hr | 513 | 581 | 10386 | 0.0559 | 0.0289 |
MCF 10A | AZD 5438 | 10 | uM | LJP6 | 3 | J01 | 72 | hr | 513 | 555 | 10494 | 0.0529 | 0.0181 |
MCF 10A | Pelitinib | 0.04 | uM | LJP5 | 1 | I18 | 72 | hr | 513 | 2065 | 10254 | 0.2014 | 0.3801 |
MCF 10A | Pelitinib | 0.04 | uM | LJP5 | 2 | I18 | 72 | hr | 513 | 2515 | 10349 | 0.2430 | 0.4430 |
MCF 10A | Pelitinib | 0.04 | uM | LJP5 | 3 | I18 | 72 | hr | 513 | 1818 | 10483 | 0.1734 | 0.3372 |
MCF 10A | Pelitinib | 0.12 | uM | LJP5 | 1 | I17 | 72 | hr | 513 | 760 | 10254 | 0.0741 | 0.0951 |
MCF 10A | Pelitinib | 0.12 | uM | LJP5 | 2 | I17 | 72 | hr | 513 | 878 | 10349 | 0.0848 | 0.1318 |
MCF 10A | Pelitinib | 0.12 | uM | LJP5 | 3 | I17 | 72 | hr | 513 | 797 | 10483 | 0.0760 | 0.1064 |
MCF 10A | Pelitinib | 0.37 | uM | LJP5 | 1 | I16 | 72 | hr | 513 | 684 | 10254 | 0.0667 | 0.0687 |
MCF 10A | Pelitinib | 0.37 | uM | LJP5 | 2 | I16 | 72 | hr | 513 | 795 | 10349 | 0.0768 | 0.1062 |
MCF 10A | Pelitinib | 0.37 | uM | LJP5 | 3 | I16 | 72 | hr | 513 | 695 | 10483 | 0.0663 | 0.0721 |
MCF 10A | Pelitinib | 1.11 | uM | LJP5 | 1 | I15 | 72 | hr | 513 | 752 | 10254 | 0.0733 | 0.0924 |
MCF 10A | Pelitinib | 1.11 | uM | LJP5 | 2 | I15 | 72 | hr | 513 | 808 | 10349 | 0.0781 | 0.1103 |
MCF 10A | Pelitinib | 1.11 | uM | LJP5 | 3 | I15 | 72 | hr | 513 | 741 | 10483 | 0.0707 | 0.0880 |
MCF 10A | Pelitinib | 3.33 | uM | LJP5 | 1 | I14 | 72 | hr | 513 | 579 | 10254 | 0.0565 | 0.0282 |
MCF 10A | Pelitinib | 3.33 | uM | LJP5 | 2 | I14 | 72 | hr | 513 | 795 | 10349 | 0.0768 | 0.1062 |
MCF 10A | Pelitinib | 3.33 | uM | LJP5 | 3 | I14 | 72 | hr | 513 | 666 | 10483 | 0.0635 | 0.0616 |
MCF 10A | Pelitinib | 10 | uM | LJP5 | 1 | I13 | 72 | hr | 513 | 529 | 10254 | 0.0516 | 0.0070 |
MCF 10A | Pelitinib | 10 | uM | LJP5 | 2 | I13 | 72 | hr | 513 | 556 | 10349 | 0.0537 | 0.0186 |